Work

Lack of Discernible Benefit of High-Dose Aspirin in the Treatment of Kawasaki Disease

Year: 2026

Type: article

Abstract: In a retrospective single-center cohort study of 460 children with Kawasaki Disease, initial treatment with low-dose aspirin and intravenous immunoglobulin (IVIG) resulted in similar coronary artery outcomes and IVIG retreatment rates compared to high-dose aspirin and IVIG. These findings support consideration of low-dose aspirin for the management of acute-phase Kawasaki Disease.

Source: Journal of the Pediatric Infectious Diseases Society

DOI: 10.1093/jpids/piag002

Authors: Lavina Thadani, Huthaifah Khan, Kwang-Youn Kim, Stanford Shulman, Anne Rowley

Institutions: Northwestern University, University of Missouri–Kansas City, Lurie Children's Hospital

Language: English

Topic: Kawasaki Disease and Coronary Complications

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7124589947